Better understanding the mutations that a tumor has not only increases researchers' knowledge of cancer, it also improves treatments for cancer patients, MIT's Phillip Sharp tells The Boston Globe. Sharp is part of the Stand Up to Cancer organization that funds "dream teams" of researchers, including one that is investigating how some cancer cell genes are turned off by DNA modifications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.